Natera to Report its Third Quarter 2024 Results on November 12, 2024
Natera, a global leader in cell-free DNA and genetic testing, has announced it will release its third quarter 2024 financial results on November 12, 2024, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Earnings Conference Call Information:
Event: |
Natera’s Third Quarter 2024 Financial Results |
Date: |
Tuesday, Nov. 12, 2024 |
Time: |
1:30 p.m. PT (4:30 p.m. ET) |
Live Dial-In: |
1-888-770-7321 (Domestic) |
|
1-929-201-7107 (International) |
Conference ID: |
7684785 |
Webcast: |
A webcast replay will be available at investor.natera.com.
About Natera
Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health, and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are validated by more than 200 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in
View source version on businesswire.com: https://www.businesswire.com/news/home/20241101997633/en/
Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-405-4709, investor@natera.com
Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., pr@natera.com
Source: Natera, Inc.